6Vataja Poaswam' a Ma-ltyta R et al. Depression-executive dysfuctions in stroke vatieris[ J]. Am. J. Geriatr Psychiatry, 2005, 13 : 99- 107.
7Robinson RG. Tile controversy over post-stroke depression and lesion location[ J ]. Psychiatric Times, 2003,20(7 ) : 39.
8Vataja R, Pohjasvaara T, Leppavuori A, et al. Magnetic resonanceimaging corelates of depression after ischemic stroke [ J ]. Arch GenPsychiatry, 2001,58 : 925-931.
9Restak RM. The mind[M]. Newyork: NY Bontam Book,1998.
10Grimsley SR, Jann MW. Paroxefine serfraline and fluroxamine: new selective se otonin reuptake in hibitors[J]. Clin pharm,1992,11:930～957.
5Pohjavaara T, Leppavuori A, Siira I, et al. Frequency and clinicaldeterminants of poststroke depression[J]. Stroke,1998,29(11):2311.
6Williams LS,Ghose SS,Swindle RW. Depression and other mentalhealth diagnoses increase mortality risk after ischemic stroke[J].Am J Psychiatry,2004,161(6) : 1090 - 1095.
7Cassidy E,Connor R,Keane V. Prevalence of poststroke depressionin an Irish sample and its relationship with disability and outcomefollowing in patient rehabilitation [ J]. Disabil Rehabil, 2004, 26(2):71-77.
8Robinson RG, Jorge RE,Clarence - Smith K. Double _ blind ran-domized treatment of poststroke depression using nefiracetam[J]. J Neuropsychiatry Clin Neurosci,2008.20:178 - 184.
9Liu X,Wei J. Pycnogenol. French maritime pine bark extract,im-proves endothelial function of hypertensive patients[J]. Life Sci-ences,2004,24(7) :855 - 862.
